271 related articles for article (PubMed ID: 25136988)
1. High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.
Lonati PA; Brembilla NC; Montanari E; Fontao L; Gabrielli A; Vettori S; Valentini G; Laffitte E; Kaya G; Meroni PL; Chizzolini C
PLoS One; 2014; 9(8):e105008. PubMed ID: 25136988
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-17A+ cell counts are increased in systemic sclerosis skin and their number is inversely correlated with the extent of skin involvement.
Truchetet ME; Brembilla NC; Montanari E; Lonati P; Raschi E; Zeni S; Fontao L; Meroni PL; Chizzolini C
Arthritis Rheum; 2013 May; 65(5):1347-56. PubMed ID: 23335253
[TBL] [Abstract][Full Text] [Related]
3. IL-22 capacitates dermal fibroblast responses to TNF in scleroderma.
Brembilla NC; Dufour AM; Alvarez M; Hugues S; Montanari E; Truchetet ME; Lonati P; Fontao L; Gabrielli A; Vettori S; Valentini G; Boehncke WH; Meroni P; Chizzolini C
Ann Rheum Dis; 2016 Sep; 75(9):1697-705. PubMed ID: 26452537
[TBL] [Abstract][Full Text] [Related]
4. Th17 cells favor inflammatory responses while inhibiting type I collagen deposition by dermal fibroblasts: differential effects in healthy and systemic sclerosis fibroblasts.
Brembilla NC; Montanari E; Truchetet ME; Raschi E; Meroni P; Chizzolini C
Arthritis Res Ther; 2013 Oct; 15(5):R151. PubMed ID: 24289089
[TBL] [Abstract][Full Text] [Related]
5. Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts.
Nakashima T; Jinnin M; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
J Immunol; 2012 Apr; 188(8):3573-83. PubMed ID: 22403442
[TBL] [Abstract][Full Text] [Related]
6. Interleukin (IL)-17F and IL-17E are related to fibrosis and vasculopathy in systemic sclerosis.
Fukayama M; Yoshizaki A; Fukasawa T; Ebata S; Kuzumi A; Yoshizaki-Ogawa A; Asano Y; Oba K; Sato S
J Dermatol; 2020 Nov; 47(11):1287-1292. PubMed ID: 32686186
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
Dufour AM; Alvarez M; Russo B; Chizzolini C
Front Immunol; 2018; 9():1865. PubMed ID: 30150989
[TBL] [Abstract][Full Text] [Related]
8. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
9. IL-25 participates in keratinocyte-driven dermal matrix turnover and is reduced in systemic sclerosis epidermis.
Russo B; Borowczyk J; Cacialli P; Moguelet P; Truchetet ME; Modarressi A; Brembilla NC; Bertrand J; Boehncke WH; Chizzolini C
Rheumatology (Oxford); 2022 Nov; 61(11):4558-4569. PubMed ID: 35171244
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis.
Robak E; Gerlicz-Kowalczuk Z; Dziankowska-Bartkowiak B; Wozniacka A; Bogaczewicz J
Arch Med Sci; 2019 May; 15(3):706-712. PubMed ID: 31110538
[TBL] [Abstract][Full Text] [Related]
11. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
[TBL] [Abstract][Full Text] [Related]
12. T-Cell Proapoptotic and Antifibrotic Activity Against Autologous Skin Fibroblasts
Vettori S; Barra G; Russo B; Borgia A; Pasquale G; Pellecchia L; Vicedomini L; De Palma R
Front Immunol; 2020; 11():220. PubMed ID: 32174912
[No Abstract] [Full Text] [Related]
13. Platelets Induce Thymic Stromal Lymphopoietin Production by Endothelial Cells: Contribution to Fibrosis in Human Systemic Sclerosis.
Truchetet ME; Demoures B; Eduardo Guimaraes J; Bertrand A; Laurent P; Jolivel V; Douchet I; Jacquemin C; Khoryati L; Duffau P; Lazaro E; Richez C; Seneschal J; Doutre MS; Pellegrin JL; Constans J; Schaeverbeke T; Blanco P; Contin-Bordes C;
Arthritis Rheumatol; 2016 Nov; 68(11):2784-2794. PubMed ID: 27429171
[TBL] [Abstract][Full Text] [Related]
14. IL-17B and IL-17C are associated with TNF-alpha production and contribute to the exacerbation of inflammatory arthritis.
Yamaguchi Y; Fujio K; Shoda H; Okamoto A; Tsuno NH; Takahashi K; Yamamoto K
J Immunol; 2007 Nov; 179(10):7128-36. PubMed ID: 17982105
[TBL] [Abstract][Full Text] [Related]
15. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.
Johansen C; Usher PA; Kjellerup RB; Lundsgaard D; Iversen L; Kragballe K
Br J Dermatol; 2009 Feb; 160(2):319-24. PubMed ID: 19016708
[TBL] [Abstract][Full Text] [Related]
17. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease.
Truchetet ME; Brembilla NC; Montanari E; Allanore Y; Chizzolini C
Arthritis Res Ther; 2011; 13(5):R166. PubMed ID: 21996293
[TBL] [Abstract][Full Text] [Related]
18. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
19. An Autotaxin/Lysophosphatidic Acid/Interleukin-6 Amplification Loop Drives Scleroderma Fibrosis.
Castelino FV; Bain G; Pace VA; Black KE; George L; Probst CK; Goulet L; Lafyatis R; Tager AM
Arthritis Rheumatol; 2016 Dec; 68(12):2964-2974. PubMed ID: 27390295
[TBL] [Abstract][Full Text] [Related]
20. Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts.
Sawamura S; Jinnin M; Inoue K; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Ihn H
J Dermatol Sci; 2018 Apr; 90(1):52-59. PubMed ID: 29336866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
